Targeted compound daraxonrasib successfully blocks multiple KRAS variants to double survival limits in clinical trials.

Northwestern Medicine scientists have demonstrated that a highly sensitive blood test can detect traces of pancreatic cancer ...

Navigating a cancer diagnosis often begins with a simple online search. The new Cancer Search Bar series from CURE brings those commonly searched questions directly to oncology ex ...

An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown ...

Every year, more than 67,000 people are diagnosed with pancreatic cancer. In most cases, the disease has spread, and patients ...

The autoimmunity associated with type 1 diabetes often begins in the first years of life, and the diagnosis of type 2 ...

The signs of pancreatic cancer are very subtle and often overlooked. Dr Sethi shares seven things to look out for to detect ...

Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news. If you’re interested in reporting on any of this month’s stories, contact media@fredhutch.org ...

Lynch syndrome, an autosomal dominant disorder caused by defective DNA mismatch repair genes, is linked to early-onset colorectal, ovarian, gastric, urinary tract and, less commonly, small bowel, ...

Pancreatic cancer's neoadjuvant debate is no longer about whether systemic therapy matters. It is about when to give it. The field is split between clinicians who view preoperative treatment as the ...